Methylation-defined tumour subgroups guide recognition of genetic predisposition in Wilms tumour
- 1Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
Abstract
Up to one-third of Wilms tumours (WTs) arise in the context of genetic or epigenetic predisposition, but identifying predisposed patients remains challenging because germline variants can be missed due to variable clinical presentation, mosaicism, and cryptic variants. We tested whether tumour-derived molecular patterns can reveal underlying predisposition and thereby complement conventional diagnostic approaches.
DNA methylation profiling of 138 WTs identified five molecular clusters that captured biological and predisposition-associated heterogeneity, including enrichment for Beckwith-Wiedemann Spectrum tumours, and a distinct WT1-driven subgroup. Cluster-guided reanalysis uncovered previously unrecognised WT1 pathogenic variants, including a newly identified germline variant that led to surveillance enrolment. A random forest classifier predicted WT1-driven tumours with [~]90% accuracy across independent validation cohorts.
Tumour methylation profiling identifies biologically and clinically relevant WT subgroups and reliably detects a WT1-driven tumour methylation signature. This approach can guide targeted variant reanalysis, and uncover clinically relevant germline variants missed by standard diagnostic workflows.
Related
- Sporadic ampullary adenoma mimicking adenocarcinoma in the absence of genetic predisposition: a case report
- Polygenic Risk and Genetic Predisposition in Post-Traumatic Epilepsy: A Framework for Risk Estimation
- Sex Differences in the Associations of Age‐Related Genetic Predisposition With Incident Atrial Fibrillation: A Prospective Cohort Study
- Diet quality and depressive symptoms in older adults, assessing the effect modification by genetic predisposition and low-grade inflammation: a target trial emulation
- High genetic predisposition and vertebral fracture burden in pregnancy and lactation-associated osteoporosis: clinical insights from a Taiwanese cohort.
BibTeX
@misc{oberhammer2026methylationdefined,
title = {{Methylation-defined tumour subgroups guide recognition of genetic predisposition in Wilms tumour}},
author = {F. Oberhammer and S. E. van Peer and N. B. Buter and F. van Dijk and R. R. de Krijger and J. J. Bakhuizen and R. S. Bladergroen and M. van Grotel and M. C. Jongmans and M. M. van den Heuvel-Eibrink and L. A. Kester and R. P. Kuiper},
howpublished = {medRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.09.26364958},
url = {https://www.medrxiv.org/content/10.64898/2026.10.09.26364958v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Methylation-defined tumour subgroups guide recognition of genetic predisposition in Wilms tumour
AU - F. Oberhammer
AU - S. E. van Peer
AU - N. B. Buter
AU - F. van Dijk
AU - R. R. de Krijger
AU - J. J. Bakhuizen
AU - R. S. Bladergroen
AU - M. van Grotel
AU - M. C. Jongmans
AU - M. M. van den Heuvel-Eibrink
AU - L. A. Kester
AU - R. P. Kuiper
PY - 2026
DA - 2026/10/09
PB - medRxiv
DO - 10.64898/2026.10.09.26364958
UR - https://www.medrxiv.org/content/10.64898/2026.10.09.26364958v1
AB - Up to one-third of Wilms tumours (WTs) arise in the context of genetic or epigenetic predisposition, but identifying predisposed patients remains challenging because germline variants can be missed due to variable clinical presentation, mosaicism, and cryptic variants. We tested whether tumour-derived molecular patterns can reveal underlying predisposition and thereby complement conventional diagnostic approaches. DNA methylation profiling of 138 WTs identified five molecular clusters that captured biological and predisposition-associated heterogeneity, including enrichment for Beckwith-Wiedemann Spectrum tumours, and a distinct WT1-driven subgroup. Cluster-guided reanalysis uncovered previously unrecognised WT1 pathogenic variants, including a newly identified germline variant that led to surveillance enrolment. A random forest classifier predicted WT1-driven tumours with [~]90% accuracy across independent validation cohorts. Tumour methylation profiling identifies biologically and clinically relevant WT subgroups and reliably detects a WT1-driven tumour methylation signature. This approach can guide targeted variant reanalysis, and uncover clinically relevant germline variants missed by standard diagnostic workflows.
ER -